Subscribe to RSS - IR

IR

IR: 'Will they do it for other products?'

 - 
07/06/2012

YARMOUTH, Maine – CMS's plan to use inherent reasonableness (IR) to set prices for retail diabetes supplies could be a sign of things to come, say industry stakeholders.